139 related articles for article (PubMed ID: 18398745)
41. Normal serum protein electrophoresis and mutated IGHV genes detect very slowly evolving chronic lymphocytic leukemia patients.
Chauzeix J; Laforêt MP; Deveza M; Crowther L; Marcellaud E; Derouault P; Lia AS; Boyer F; Bargues N; Olombel G; Jaccard A; Feuillard J; Gachard N; Rizzo D
Cancer Med; 2018 Jun; 7(6):2621-2628. PubMed ID: 29745034
[TBL] [Abstract][Full Text] [Related]
42. Chronic Lymphocytic Leukemia with Mutated IGHV4-34 Receptors: Shared and Distinct Immunogenetic Features and Clinical Outcomes.
Xochelli A; Baliakas P; Kavakiotis I; Agathangelidis A; Sutton LA; Minga E; Ntoufa S; Tausch E; Yan XJ; Shanafelt T; Plevova K; Boudjogra M; Rossi D; Davis Z; Navarro A; Sandberg Y; Vojdeman FJ; Scarfo L; Stavroyianni N; Sudarikov A; Veronese S; Tzenou T; Karan-Djurasevic T; Catherwood M; Kienle D; Chatzouli M; Facco M; Bahlo J; Pott C; Pedersen LB; Mansouri L; Smedby KE; Chu CC; Giudicelli V; Lefranc MP; Panagiotidis P; Juliusson G; Anagnostopoulos A; Vlahavas I; Antic D; Trentin L; Montillo M; Niemann C; Döhner H; Langerak AW; Pospisilova S; Hallek M; Campo E; Chiorazzi N; Maglaveras N; Oscier D; Gaidano G; Jelinek DF; Stilgenbauer S; Chouvarda I; Darzentas N; Belessi C; Davi F; Hadzidimitriou A; Rosenquist R; Ghia P; Stamatopoulos K
Clin Cancer Res; 2017 Sep; 23(17):5292-5301. PubMed ID: 28536306
[No Abstract] [Full Text] [Related]
43. SF3B1 and IGHV gene mutation status predict poor prognosis in Japanese CLL patients.
Mitsui T; Koiso H; Nakahashi H; Saitoh A; Shimizu H; Ishizaki T; Ogawa Y; Takizawa M; Yokohama A; Saitoh T; Jinbo T; Ogura H; Handa H; Sawamura M; Sakura T; Karasawa M; Murakami H; Nojima Y; Tsukamoto N
Int J Hematol; 2016 Feb; 103(2):219-26. PubMed ID: 26588928
[TBL] [Abstract][Full Text] [Related]
44. Mutation status and immunoglobulin gene rearrangements in patients from northwest and central region of Spain with chronic lymphocytic leukemia.
González-Gascón Y Marín I; Hernández JA; Martín A; Alcoceba M; Sarasquete ME; Rodríguez-Vicente A; Heras C; de Las Heras N; Fisac R; García de Coca A; de la Fuente I; Hernández-Sánchez M; Recio I; Galende J; Martín-Núñez G; Alonso JM; Hernández-Rivas JM; González M
Biomed Res Int; 2014; 2014():257517. PubMed ID: 24790994
[TBL] [Abstract][Full Text] [Related]
45. Chronic lymphocytic leukemia patients with highly stable and indolent disease show distinctive phenotypic and genotypic features.
Guarini A; Gaidano G; Mauro FR; Capello D; Mancini F; De Propris MS; Mancini M; Orsini E; Gentile M; Breccia M; Cuneo A; Castoldi G; Foa R
Blood; 2003 Aug; 102(3):1035-41. PubMed ID: 12676780
[TBL] [Abstract][Full Text] [Related]
46. Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features.
Bomben R; Dal-Bo M; Benedetti D; Capello D; Forconi F; Marconi D; Bertoni F; Maffei R; Laurenti L; Rossi D; Del Principe MI; Luciano F; Sozzi E; Cattarossi I; Zucchetto A; Rossi FM; Bulian P; Zucca E; Nicoloso MS; Degan M; Marasca R; Efremov DG; Del Poeta G; Gaidano G; Gattei V
Clin Cancer Res; 2010 Jan; 16(2):620-8. PubMed ID: 20068100
[TBL] [Abstract][Full Text] [Related]
47. An Immunogenetic Signature of Ongoing Antigen Interactions in Splenic Marginal Zone Lymphoma Expressing IGHV1-2*04 Receptors.
Bikos V; Karypidou M; Stalika E; Baliakas P; Xochelli A; Sutton LA; Papadopoulos G; Agathangelidis A; Papadopoulou E; Davis Z; Algara P; Kanellis G; Traverse-Glehen A; Mollejo M; Anagnostopoulos A; Ponzoni M; Gonzalez D; Pospisilova S; Matutes E; Piris MA; Papadaki T; Ghia P; Rosenquist R; Oscier D; Darzentas N; Tzovaras D; Belessi C; Hadzidimitriou A; Stamatopoulos K
Clin Cancer Res; 2016 Apr; 22(8):2032-40. PubMed ID: 26647217
[TBL] [Abstract][Full Text] [Related]
48. Molecular characterization of immunoglobulin gene rearrangements in diffuse large B-cell lymphoma: antigen-driven origin and IGHV4-34 as a particular subgroup of the non-GCB subtype.
Sebastián E; Alcoceba M; Balanzategui A; Marín L; Montes-Moreno S; Flores T; González D; Sarasquete ME; Chillón MC; Puig N; Corral R; Pardal E; Martín A; González-Barca E; Caballero MD; San Miguel JF; García-Sanz R; González M
Am J Pathol; 2012 Nov; 181(5):1879-88. PubMed ID: 22982190
[TBL] [Abstract][Full Text] [Related]
49. IGHV1-69 B cell chronic lymphocytic leukemia antibodies cross-react with HIV-1 and hepatitis C virus antigens as well as intestinal commensal bacteria.
Hwang KK; Trama AM; Kozink DM; Chen X; Wiehe K; Cooper AJ; Xia SM; Wang M; Marshall DJ; Whitesides J; Alam M; Tomaras GD; Allen SL; Rai KR; McKeating J; Catera R; Yan XJ; Chu CC; Kelsoe G; Liao HX; Chiorazzi N; Haynes BF
PLoS One; 2014; 9(3):e90725. PubMed ID: 24614505
[TBL] [Abstract][Full Text] [Related]
50. Not all IGHV3-21 chronic lymphocytic leukemias are equal: prognostic considerations.
Baliakas P; Agathangelidis A; Hadzidimitriou A; Sutton LA; Minga E; Tsanousa A; Scarfò L; Davis Z; Yan XJ; Shanafelt T; Plevova K; Sandberg Y; Vojdeman FJ; Boudjogra M; Tzenou T; Chatzouli M; Chu CC; Veronese S; Gardiner A; Mansouri L; Smedby KE; Pedersen LB; Moreno D; Van Lom K; Giudicelli V; Francova HS; Nguyen-Khac F; Panagiotidis P; Juliusson G; Angelis L; Anagnostopoulos A; Lefranc MP; Facco M; Trentin L; Catherwood M; Montillo M; Geisler CH; Langerak AW; Pospisilova S; Chiorazzi N; Oscier D; Jelinek DF; Darzentas N; Belessi C; Davi F; Ghia P; Rosenquist R; Stamatopoulos K
Blood; 2015 Jan; 125(5):856-9. PubMed ID: 25634617
[TBL] [Abstract][Full Text] [Related]
51. Over 30% of patients with splenic marginal zone lymphoma express the same immunoglobulin heavy variable gene: ontogenetic implications.
Bikos V; Darzentas N; Hadzidimitriou A; Davis Z; Hockley S; Traverse-Glehen A; Algara P; Santoro A; Gonzalez D; Mollejo M; Dagklis A; Gangemi F; Bosler DS; Bourikas G; Anagnostopoulos A; Tsaftaris A; Iannitto E; Ponzoni M; Felman P; Berger F; Belessi C; Ghia P; Papadaki T; Dogan A; Degano M; Matutes E; Piris MA; Oscier D; Stamatopoulos K
Leukemia; 2012 Jul; 26(7):1638-46. PubMed ID: 22222599
[TBL] [Abstract][Full Text] [Related]
52. V(H)3-21 gene usage in chronic lymphocytic leukemia--characterization of a new subgroup with distinct molecular features and poor survival.
Tobin G; Söderberg O; Thunberg U; Rosenquist R
Leuk Lymphoma; 2004 Feb; 45(2):221-8. PubMed ID: 15101705
[TBL] [Abstract][Full Text] [Related]
53. [Expression of stereotyped B-cell receptor and its clinical value in chronic lymphocytic leukemia].
Yu Z; Li ZJ; Yi SH; Zhou KS; Hao M; Li CH; Qi JY; Qiu LG
Zhonghua Yi Xue Za Zhi; 2011 Dec; 91(46):3267-70. PubMed ID: 22333147
[TBL] [Abstract][Full Text] [Related]
54. Prognostic usage of V(H) gene mutation status and its surrogate markers and the role of antigen selection in chronic lymphocytic leukemia.
Tobin G; Rosenquist R
Med Oncol; 2005; 22(3):217-28. PubMed ID: 16110132
[TBL] [Abstract][Full Text] [Related]
55. Comprehensive characterization of immunoglobulin gene rearrangements in patients with chronic lymphocytic leukaemia.
René C; Prat N; Thuizat A; Broctawik M; Avinens O; Eliaou JF
J Cell Mol Med; 2014 Jun; 18(6):979-90. PubMed ID: 24725733
[TBL] [Abstract][Full Text] [Related]
56. Subjects with chronic lymphocytic leukaemia-like B-cell clones with stereotyped B-cell receptors frequently show MDS-associated phenotypes on myeloid cells.
Rodríguez-Caballero A; Henriques A; Criado I; Langerak AW; Matarraz S; López A; Balanzategui A; González M; Nieto WG; Cortesão E; Paiva A; Almeida J; Orfao A
Br J Haematol; 2015 Jan; 168(2):258-67. PubMed ID: 25252186
[TBL] [Abstract][Full Text] [Related]
57. Immunoglobulin gene segment usage, location and immunogenicity in mutated and unmutated chronic lymphocytic leukaemia.
Mauerer K; Zahrieh D; Gorgun G; Li A; Zhou J; Ansén S; Rassenti LZ; Gribben JG
Br J Haematol; 2005 May; 129(4):499-510. PubMed ID: 15877732
[TBL] [Abstract][Full Text] [Related]
58. Identical IGHV-D-J gene rearrangement may precede the clinical onset of chronic lymphocytic leukemia by several years.
Frezzato M; Giaretta I; Madeo D; Rodeghiero F
Am J Hematol; 2010 Nov; 85(11):868-71. PubMed ID: 20872553
[TBL] [Abstract][Full Text] [Related]
59. Pathology consultation on evaluating prognosis in incidental monoclonal lymphocytosis and chronic lymphocytic leukemia.
Siddon AJ; Rinder HM;
Am J Clin Pathol; 2013 Jun; 139(6):708-12. PubMed ID: 23690112
[TBL] [Abstract][Full Text] [Related]
60. Analysis of the 3'UTR region of the NOTCH1 gene in chronic lymphocytic leukemia patients.
Abramenko IV; Bilous NI; Chumak AA; Dyagil IS; Martina ZV
Exp Oncol; 2018 Oct; 40(3):211-217. PubMed ID: 30284999
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
